DENTSPLY SIRONA (NASDAQ:XRAY) Now Covered by Wells Fargo & Company

Analysts at Wells Fargo & Company began coverage on shares of DENTSPLY SIRONA (NASDAQ:XRAY) in a research report issued on Friday,Briefing.com Automated Import reports. The firm set an “equal weight” rating and a $20.00 price target on the medical instruments supplier’s stock. Wells Fargo & Company‘s target price suggests a potential upside of 6.55% from the company’s previous close.

A number of other equities research analysts have also recently commented on XRAY. Robert W. Baird decreased their price target on DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating for the company in a research note on Friday, November 8th. Morgan Stanley decreased their price target on DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating for the company in a research note on Tuesday, December 17th. StockNews.com upgraded DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research note on Friday, February 7th. Mizuho started coverage on DENTSPLY SIRONA in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $21.00 price target for the company. Finally, Leerink Partnrs cut DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a research note on Thursday, November 7th. Ten equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $25.85.

DENTSPLY SIRONA Trading Up 2.2 %

Shares of NASDAQ XRAY opened at $18.77 on Friday. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. The stock has a market capitalization of $3.73 billion, a P/E ratio of -9.07, a price-to-earnings-growth ratio of 1.83 and a beta of 0.96. DENTSPLY SIRONA has a 1-year low of $17.21 and a 1-year high of $34.91. The business has a fifty day moving average price of $19.04 and a 200 day moving average price of $22.04.

Hedge Funds Weigh In On DENTSPLY SIRONA

Large investors have recently modified their holdings of the business. Riverview Trust Co acquired a new position in DENTSPLY SIRONA during the 4th quarter worth about $26,000. Capital Performance Advisors LLP purchased a new stake in DENTSPLY SIRONA during the 3rd quarter worth about $27,000. MassMutual Private Wealth & Trust FSB increased its holdings in DENTSPLY SIRONA by 648.4% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier’s stock worth $27,000 after purchasing an additional 1,232 shares during the period. UMB Bank n.a. increased its holdings in shares of DENTSPLY SIRONA by 60.8% in the 4th quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier’s stock valued at $28,000 after acquiring an additional 564 shares during the last quarter. Finally, Mitsubishi UFJ Asset Management Co. Ltd. increased its holdings in shares of DENTSPLY SIRONA by 700.0% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,792 shares of the medical instruments supplier’s stock valued at $33,000 after acquiring an additional 1,568 shares during the last quarter. Institutional investors and hedge funds own 95.70% of the company’s stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.